Tigermed Reports 2022 Interim Result with Strong Financial Growth

Adella Miesner

HANGZHOU, China, Aug. 25, 2022 /PRNewswire/ — Hangzhou Tigermed Consulting Co., Ltd. (“Tigermed” or the “company”) (Stock code: 300347.SZ / 3347.HK), a leading global provider of integrated research and development solutions for biopharmaceutical and medical device industry, announced its interim results for the first half of 2022, ended June 30, […]